' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

STRUNK DIRK
Universitätsinstitut für experimentelle und klinische Zelltherapie
Zentrum für Querschnitt- und Geweberegeneration Salzburg

Publikationen | Forscherprofil

306 Publikationen

2018

Beiträge in Fachzeitschriften

Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes.
Guttmann-Gruber, C; Tockner, B; Scharler, C; Hüttner, C; Common, JE; Tay, ASL; Denil, SLIJ; Klausegger, A; Trost, A; Breitenbach, J; Schnitzhofer, P; Hofbauer, P; Wolkersdorfer, M; Diem, A; Laimer, M; Strunk, D; Bauer, JW; Reichelt, J; Lang, R; Piñón Hofbauer, J;
Sci Rep. 2018; 8(1): 13430
Originalarbeiten (Zeitschrift)
Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer.
Hochmann, S; Mittermeir, M; Santic, R; Koszik, F; Griessner, L; Sonderegger, AS; Hoffmann, T; Russe, E; Scheiblhofer, S; Weiss, R; Mandler, M; Schneeberger, A; Strunk, D;
Sci Rep. 2018; 8(1): 12954
Originalarbeiten (Zeitschrift)
Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal Cells
Oeller, M; Laner-Plamberger, S; Hochmann, S; Ketterl, N; Feichtner, M; Brachtl, G; Hochreiter, A; Scharler, C; Bieler, L; Romanelli, P; Couillard-Despres, S; Russe, E; Schallmoser, K; Strunk, D
THERANOSTICS. 2018; 8(5): 1421-1434.
Originalarbeiten (Zeitschrift)
International Forum on GMP-grade human platelet lysate for cell propagation.
Strunk, D; Lozano, M; Marks, DC; Loh, YS; Gstraunthaler, G; Schennach, H; Rohde, E; Laner-Plamberger, S; Öller, M; Nystedt, J; Lotfi, R; Rojewski, M; Schrezenmeier, H; Bieback, K; Schäfer, R; Bakchoul, T; Waidmann, M; Jonsdottir-Buch, SM; Montazeri, H; Sigurjonsson, OE; Iudicone, P; Fioravanti, D; Pierelli, L; Introna, M; Capelli, C; Falanga, A; Takanashi, M; López-Villar, O; Burnouf, T; Reems, JA; Pierce, J; Preslar, AM; Schallmoser, K;
Vox Sang. 2018; 113(1):e1-e25
Letter
International Forum on GMP-grade human platelet lysate for cell propagation: summary.
Strunk, D; Lozano, M; Marks, DC; Loh, YS; Gstraunthaler, G; Schennach, H; Rohde, E; Laner-Plamberger, S; Öller, M; Nystedt, J; Lotfi, R; Rojewski, M; Schrezenmeier, H; Bieback, K; Schäfer, R; Bakchoul, T; Waidmann, M; Jonsdottir-Buch, SM; Montazeri, H; Sigurjonsson, OE; Iudicone, P; Fioravanti, D; Pierelli, L; Introna, M; Capelli, C; Falanga, A; Takanashi, M; Lόpez-Villar, O; Burnouf, T; Reems, JA; Pierce, J; Preslar, AM; Schallmoser, K;
Vox Sang. 2018; 113(1):80-87
Übersichtsarbeiten
Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation.
Trento, C; Bernardo, ME; Nagler, A; Kuçi, S; Bornhäuser, M; Köhl, U; Strunk, D; Galleu, A; Sanchez-Guijo, F; Gaipa, G; Introna, M; Bukauskas, A; Le Blanc, K; Apperley, J; Roelofs, H; Van Campenhout, A; Beguin, Y; Kuball, J; Lazzari, L; Avanzini, MA; Fibbe, W; Chabannon, C; Bonini, C; Dazzi, F;
Biol Blood Marrow Transplant. 2018; 24(11):2365-2370
Originalarbeiten (Zeitschrift)
Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial.
Tripolt, NJ; Aberer, F; Riedl, R; Url, J; Dimsity, G; Meinitzer, A; Stojakovic, T; Aziz, F; Hödl, R; Brachtl, G; Strunk, D; Brodmann, M; Hafner, F; Sourij, H;
Cardiovasc Diabetol. 2018; 17(1): 71
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Influence of Heparin on Gene Expression of Stromal Cells Derived from Different Tissues
Laner-Plamberger, S; Oeller, M; Kalathur, R; Poupardin, R; Hochmann, S; Brachtl, G; Pachler, K; Kreutzer, C; Strunk, D; Rohde, E; Schallmoser, K
TRANSFUSION. 2018; 58: 66A-67A.
Abstracts (Zeitschrift)
Plasma Rotational Thrombelastometry for Evaluation of Hemocompatibility of Human Umbilical Cord Derived Stromal Cells
M. Oeller, S. Laner-Plamberger, G. Brachtl, E. Rohde, D. Strunk & K. Schallmoser
Transfusion. 2018; 58: 68A-69A.-AABB Annual Meeting; 13.-16.10.2018; Boston.
Abstracts (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Towards better understanding of extracellular vesicle-mediated stroma-leukemia crosstalk in the bone marrow niche.
Girgis, R; Raninger, A; Hochreiter, A; Obermayer, A; Schallmoser, K; Brachtl, G; Wolf, M; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Development of a human 3D vascularized skin organoid model.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
6th Annual GSCN Conference; 19.-21.09.2018; Heidelberg. 2018.
Development of a human 3D vascularized skin organoid model.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
26th Annual Congress of the ESGCT; 16.-19.10.2018; Lausanne. 2018.
Development of an iPSC-mediated strategy for skin regeneration.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Development of a human 3D vascularized skin organoid model.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Development of an iPSC-mediated strategy for skin regeneration.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
2018 ESDR Future Leaders Academy; 03.-05.10.2018; Budapest. 2018.
Development of immunosuppressive iPSC-derived stromal cells for tissue regeneration.
Peking, P; Scharler, C; Ketterl, N; Hochreiter, A; Jürchott, K; Höfler, M; Brachtl, G; Wimmer, M; Wolf, M; Hochmann, S; Schallmoser, K; Volk, H-D; Strunk, D
6th Annual GSCN Conference; 19.-21.09.2018; Heidelberg. 2018.
NO IDENTICAL STROMAL CELLS: TRANSCRIPTOMIC META-ANALYSIS HIGHLIGHTS DIFFERENCES BETWEEN BONE-MARROW-DERIVED MESENCHYMAL STROMAL/PROGENITOR CELLS AND OTHER STROMAL CELL SOURCES.
Poupardin, R; Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Schallmoser, K; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
NO IDENTICAL STROMAL CELLS: TRANSCRIPTOMIC META-ANALYSIS HIGHLIGHTS DIFFERENCES BETWEEN BONE-MARROW-DERIVED MESENCHYMAL STROMAL/PROGENITOR CELLS AND OTHER STROMAL CELL SOURCES.
Poupardin, R; Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Schallmoser, K; Strunk, D
6th Annual GSCN Conference; 19.-21.09.2018; Heidelberg. 2018.
No identical MSC: Which stromal cells can be used for cardiac regeneration
Strunk, D
TECHNOBEAT Satellite Meeting for Regenerative Medicine: From iPSCs to Translation; 06.03.2018; Weizmann Institute of Science, Rehovot, Tel Aviv. 2018.
Stammzelltherapie und regenerative Medizin
Strunk, D
FOKUS:PRAXIS Blut; 29.09.2018; Wien. 2018.
Advanced cell therapies: Remaining preclinical and clinical challenges.
Strunk, D
Anniversary Symposium of the Julius Wolff Institute, Universitätsmedizin Charité Berlin; 14.-15.06.2018; Berlin. 2018.
Do we need engraftment in regenerative stem cell therapy?
Strunk, D
Lecture Series of the Center for Pathobiochemistry and Genetics; 20.11.2018; Wien. 2018.
The role of EVs in vascular regeneration and immunomodulation.
Strunk, D
Annual Meeting on Extracellular Vesicles; 22.-23.11.2018; Krems. 2018.
Placental stromal cell-derived extracellular vesicles display immunomodulatory capacity and pro-angiogenic function.
Wolf, M; Vári, B; Raninger, A; Obermayer, A; Poupardin, R; Schallmoser, K; Ofir, R; Strunk, D
26th Annual Congress of the ESGCT; 16.-19.10.2018; Lausanne. 2018.
Placental stromal cell-derived extracellular vesicles display immunomodulatory capacity and pro-angiogenic function.
Wolf, M; Vári, B; Raninger, A; Obermayer, A; Poupardin, R; Schallmoser, K; Ofir, R; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Placental stromal cell-derived extracellular vesicles display immunomodulatory capacity and pro-angiogenic function.
Wolf, M; Vári, B; Raninger, A; Obermayer, A; Poupardin, R; Schallmoser, K; Ofir, R; Strunk, D
6th Annual GSCN Conference; 19.-21.09.2018; Heidelberg. 2018.

2017

Beiträge in Fachzeitschriften

Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy.
Machado, Y; Duinkerken, S; Hoepflinger, V; Mayr, M; Korotchenko, E; Kurtaj, A; Pablos, I; Steiner, M; Stoecklinger, A; Lübbers, J; Schmid, M; Ritter, U; Scheiblhofer, S; Ablinger, M; Wally, V; Hochmann, S; Raninger, AM; Strunk, D; van Kooyk, Y; Thalhamer, J; Weiss, R;
J Control Release. 2017; 266: 87-99.
Originalarbeiten (Zeitschrift)
An In Vitro Potency Assay for Monitoring the Immunomodulatory Potential of Stromal Cell-Derived Extracellular Vesicles.
Pachler, K; Ketterl, N; Desgeorges, A; Dunai, ZA; Laner-Plamberger, S; Streif, D; Strunk, D; Rohde, E; Gimona, M;
Int J Mol Sci. 2017; 18(7):
Originalarbeiten (Zeitschrift)
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma.
Sheffield, NC; Pierron, G; Klughammer, J; Datlinger, P; Schönegger, A; Schuster, M; Hadler, J; Surdez, D; Guillemot, D; Lapouble, E; Freneaux, P; Champigneulle, J; Bouvier, R; Walder, D; Ambros, IM; Hutter, C; Sorz, E; Amaral, AT; de Álava, E; Schallmoser, K; Strunk, D; Rinner, B; Liegl-Atzwanger, B; Huppertz, B; Leithner, A; de Pinieux, G; Terrier, P; Laurence, V; Michon, J; Ladenstein, R; Holter, W; Windhager, R; Dirksen, U; Ambros, PF; Delattre, O; Kovar, H; Bock, C; Tomazou, EM;
Nat Med. 2017; 23(3): 386-395.
Originalarbeiten (Zeitschrift)
Stromal Cells Act as Guardians for Endothelial Progenitors by Reducing Their Immunogenicity After Co-Transplantation.
Souidi, N; Stolk, M; Rudeck, J; Strunk, D; Schallmoser, K; Volk, HD; Seifert, M;
Stem Cells. 2017; 35(5): 1233-1245.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Regenerative potential of periosteum-derived stromal cells
Brachtl, G; Hochreiter, A; Hochmann, S; Mittermeir, M; Raninger, A; Schallmoser, K; Wittig, J; Gaggl, A; Strunk, D
Human Gene Therapy. 2017; 28: A89-A90.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
Addressing skin with in vitro transcribed mRNA
Hochmann, S; Mittermeir, M; Santic, R; Scharler, C; Scheiblhofer, S; Russe, E; Weiss, R; Mandler, M; Schneeberger, A; Strunk, D
Human Gene Therapy. 2017; 28: A85-A85.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
No identical stromal cells: Human stromal progenitors from non-skeletal sources display limited chondrogenic potential.
Hochmann, S; Scharler, C; Textor, M; Mittermeir, M; Brachtl, G; Föttinger, P; Hochreiter, A; Schmidt-Bleek, K; Ellinghaus, A; Geissler, S; Duda, G; Strunk, D
Human Gene Therapy. 2017; 28: A84-A84.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
A potency assay for monitoring the immunomodulatory potential of stromal cell-derived extracellular vesicles.
Ketterl, N; Pachler, K; Desgeorges, A; Dunai, Z; Laner-Plamberger, S; Streif, D; Strunk, D; Rohde, E; Gimona, M
Human Gene Therapy. 2017; 28: A85-A86.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
Human Platelet Lysate Modifications Affect Mesenchymal Stromal Cell Biology Depending on Cell Origin
Laner-Plamberger, S; Öller, M; Brachtl, G; Strunk, D; Hartl, A; Pachler, K; Feichtner, M; Hauser-Kronberger, C; Wiedemann, H; Rohde, E; Schallmoser, K
Vox Sanguinis. 2017; 112(1):285-286.-27th Regional Congress of the International Society of Blood Transfusion; 17.06.-21.06.2017; Copenhagen.
Abstracts (Zeitschrift)
Heparin Changes the Gene Expression Profile of Mesenchymal Stem/Progenitor Cells
Laner-Plamberger, S; Öller, M; Kalathur, R; Strunk, D; Feichtner, M; Pachler, K; Hauser-Kronberger, C; Schallmoser, K; Rohde, E
Vox Sanguinis. 2017; 112(1):66-66.-27th Regional Congress of the International Society of Blood Transfusion; 17.06.-21.06.2017; Copenhagen.
Abstracts (Zeitschrift)
Heparin affects gene expression of mesenchymal stromal cells in a source-dependent manner
Laner-Plamberger, S; Oller, M; Kalathur, R; Strunk, D; Pachler, K; Hauser-Kronberger, C; Schallmoser, K; Rohde, E
TRANSFUS MED HEMOTH. 2017; 44: 80-81.
Abstracts (Zeitschrift)
Heparin affects Gene Expression of Mesenchymal Stromal Cells in a Source-dependent Manner
Laner-Plamberger, S; Öller, M; Kalathur, R; Strunk, D; Pachler, K; Hauser-Kronberger, C; Schallmoser, K; Rohde, E
Transfusion Medicine and Hemotherapy. 2017; 44(Suppl.1):p.80--50.Jahrestagung der DGTI; 24.-27.10.2017; Köln.
Abstracts (Zeitschrift)
Hemocompatibility of stromal cells depends on tissue factor expression and is influenced by organ origin and culture conditions
Oeller, M; Laner-Plamberger, S; Feichtner, M; Brachtl, G; Dunai, ZA; Russe, E; Rohde, E; Strunk, D; Schallmoser, K
TRANSFUS MED HEMOTH. 2017; 44: 74-74.
Abstracts (Zeitschrift)
Selection of tissue factor-deficient bone marrow stromal cell transplants as a novel strategy to improve therapeutic applicability
Oeller, M; Laner-Plamberger, S; Ketterl, N; Feichtner, M; Raninger, A; Hochreiter, A; Brachtl, G; Dunai, ZA; Russe, E; Schulte, M; Rohde, E; Schallmoser, K; Strunk, D
Human Gene Therapy. 2017; 28: A97-A98.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
Tissue Factor Expression and Hemocompatibility of Stromal Cells Depend on Organ Origin and Culture Conditions
Öller, M; Laner-Plamberger, S; Feichtner, M; Brachtl, G; Dunai, Z; Russe, E; Rohde, E; Strunk, D; Schallmoser, K
Vox Sanguinis. 2017; 112(1):65-66.-27th Regional Congress of the International Society of Blood Transfusion; 17.06.-21.06.2017; Copenhagen.
Abstracts (Zeitschrift)
Hemocompatibility of stromal cells depends on tissue factor expression and is influenced by organ origin and culture
Öller, M; Laner-Plamberger, S; Feichtner, M; Brachtl, G; Dunai, ZA; Russe, E; Rohde, E; Strunk, D; Schallmoser, K
Transfusion Medicine and Hemotherapy. 2017; 44(Suppl.1):p.74--50.Jahrestagung der DGTI; 24.-27.10.2017; Köln.
Abstracts (Zeitschrift)
Neuroprotective activity of mesenchymal stromal cells and their secreted vesicles in a spinal cord contusion rat model
Romanelli, P; Bieler, L; Scharler, C; Pachler, K; Kreutzer, C; Zaunmair, P; Aigner, L; Rivera, FJ; Rohde, E; Benedetti, B; Gimona, M; Strunk, D; Couillard-Despres, S
TRANSFUS MED HEMOTH. 2017; 44: 76-76.
Abstracts (Zeitschrift)
Stepwise maturation of human iPSC into clonogenic immunosuppressive mesodermal stromal progenitors identifies key immunomodulatory pathways.
Scharler, C; Ketterl, N; Jürchott, K; Brachtl, G; Schallmoser, K; Volk, HD; Strunk, D
Human Gene Therapy. 2017; 28: A83-A84.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
Significantly Reduced CFU-F Frequency and Increased Adipogenic Differentiation of Mesenchymal Stem Cells (Msc) in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
Weickert, MT; Garz, AK; Hecker, J; Ziegenhain, C; Grath, S; Strunk, D; Peschel, C; Enard, W; Oostendorp, RAJ; Gotze, KS
ANN HEMATOL. 2017; 96: S52-S52.
Abstracts (Zeitschrift)
Transcriptome profiling in recessive dystrophic epidermolysis bullosa patients
Zauner, R; Wimmer, M; Lettner, T; Gruber, C; Murauer, EM; Reichelt, J; Strunk, D; Bauer, JW; Wally, V
J INVEST DERMATOL. 2017; 137(10): S288-S288.
Abstracts (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Addressing skin with IVT mRNA
Hochmann, S; Mittermeir, M; Santic, R; Scharler, C; Scheiblhofer, S; Russe, E; Weiss, R; Mandler, M; Schneeberger, A; Strunk, D
25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin. 2017.
Human mesenchymal progenitors from non-skeletal adult sources display limited chondrogenic Differentiation.
Hochmann, S; Scharler, C; Textor, M; Mittermeir, M; Brachtl, G; Föttinger, P; Hochreiter, A; Geissler, S; Strunk, D
ISSCR Annual Meeting; 14.-17.06.2017; Boston. 2017.
No Identical Stromal Cells: Human Stromal Progenitors from Non-Skeletal Sources Display Limited Chondrogenic Potential
Hochmann, S; Scharler, C; Textor, M; Mittermeir, M; Brachtl, G; Föttinger, P; Hochreiter, A; Schmidt-Bleek, K; Ellinghaus, A; Geissler, S; Duda, G; Strunk, D
25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin. 2017.
Selection of tissue factor-deficient bone marrow stromal cell transplants as a novel strategy to improve therapeutic applicability
Öller, M; Laner-Plamberger, S; Ketterl, N; Feichtner, M; Raninger, A; Hochreiter, A; Brachtl, G; Dunai, ZA; Russe, E; Schulte, M; Rohde, E; Schallmoser, K; Strunk D
25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin. 2017.
Stepwise maturation of human iPSC into clonogenic immunosuppressive mesodermal stromal progenitors identifies key immunomodulatory pathways
Scharler, C; Ketterl, N; Jürchott, K; Brachtl, G; Schallmoser, K; Volk, HD; Strunk, D
25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin. 2017.
No Identical MSC: Human Stromal Progenitors from Non-Skeletal Sources Display Limited Chondrogenic Potential - Implications for Clinical Trials.
Strunk, D
PEI-GSCN Workshop; 06.11.2017; Berlin. 2017.
Why We Develop iPSC Therapy Strategies.
Strunk, D
EACTS-PACT Joint Symposium "Regenerative Medicine: Taking the Science to the Patient"; 30.11.-01.12.2017; Wien. 2017.
Stromal Cell Therapy: Past – Presence – Future.
Strunk, D
Jahrestagung 2017 der ÖGBT; 22.-24.05.2017; Seggau. 2017.

2016

Beiträge in Fachzeitschriften

Human platelet lysate: Replacing fetal bovine serum as a gold standard for human cell propagation?
Burnouf, T; Strunk, D; Koh, MB; Schallmoser, K;
Biomaterials. 2016; 76: 371-387.
Übersichtsarbeiten
Cryopreserved or Fresh Mesenchymal Stromal Cells: Only a Matter of Taste or Key to Unleash the Full Clinical Potential of MSC Therapy?
Moll, G; Geißler, S; Catar, R; Ignatowicz, L; Hoogduijn, MJ; Strunk, D; Bieback, K; Ringdén, O;
Adv Exp Med Biol. 2016; 951: 77-98.
Originalarbeiten (Zeitschrift)
A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells.
Reinisch, A; Thomas, D; Corces, MR; Zhang, X; Gratzinger, D; Hong, WJ; Schallmoser, K; Strunk, D; Majeti, R;
Nat Med. 2016; 22(7): 812-821.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Leukotriene receptor inhibition mobilizes human stem cells in vivo
Brachtl, G; Hochreiter, A; Jacobs, VR; Schafer, R; Strunk, D
HUM GENE THER. 2016; 27(11): A56-A56.
Abstracts (Zeitschrift)
GMP-Compliant Production of Pooled Human Platelet Lysate – Setting Standards for Xeno-free Cell Propagation
Feichtner, M; Öller, M; Laner-Plamberger, S; Wiedemann, H; Rohde, E; Strunk, D; Schallmoser, K
Transfusion Medicine and Hemotherapy. 2016; 43(Suppl. 1):73--49. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie ; 07.-10.09.2016; Nürnberg.
Abstracts (Zeitschrift)
Calcipotriol enhances cathelicidin expression and improves bacterial defense and wound closure in epidermolysis bullosa
Gruber, C; Hofbauer, P; Tockner, B; Scharler, C; Huttner, C; Trost, A; Strunk, D; Bauer, JW; Reichelt, J; Lang, R
EXP DERMATOL. 2016; 25: 35-36.
Abstracts (Zeitschrift)
Understanding the molecular landscape of human bone marrow-derived mesenchymal stem/progenitor cells through meta-analysis
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
HUM GENE THER. 2016; 27(11): A65-A65.
Abstracts (Zeitschrift)
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs)
Ketterl, N; Brachtl, G; Scharler, C; Schallmoser, K; Reinisch, A; Strunk, D
HUM GENE THER. 2016; 27(11): A64-A65.
Abstracts (Zeitschrift)
Influence of heparin on the genomic profile of human mesenchymal stromal/progenitor cells
Laner-Plamberger, S; Oller, M; Kalathur, R; Brachtl, G; Strunk, D; Feichtner, M; Hauser-Kronberger, C; Schallmoser, K; Rohde, E
HUM GENE THER. 2016; 27(11): A61-A61.
Abstracts (Zeitschrift)
Efficient expansion of mesenchymal stem/progenitor cells supported by fibrinogen-depleted pooled human platelet lysate
Oller, M; Laner-Plamberger, S; Feichtner, M; Dunai, ZA; Raninger, A; Gimona, M; Hartl, A; Hauser-Kronberger, C; Russe, E; Bieback, K; Rohde, E; Brachtl, G; Scharler, C; Strunk, D; Schallmoser, K
HUM GENE THER. 2016; 27(11): A63-A64.
Abstracts (Zeitschrift)
Efficient Expansion of Mesenchymal Stromal Cells by Fibrinogen-Depleted Pooled Human Platelet Lysate
Öller, M; Laner-Plamberger, S; Feichtner, M; Dunai, ZA; Raninger, A; Gimona, M; Hartl, A; Hauser-Kronberger, C; Russe, E; Bieback, K; Rohde, E; Brachtl, G; Scharler, C; Strunk, D; Schallmoser, K
Transfusion Medicine and Hemotherapy. 2016; 43(Suppl.1):71--49. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie ; 07.-10.09.2016; Nürnberg.
Abstracts (Zeitschrift)
Fibrinogen-Depleted Pooled Human Platelet Lysate for Efficient Expansion of Mesenchymal Stromal Cells
Öller, M; Laner-Plamberger, S; Feichtner, M; Dunai, ZA; Raninger, A; Gimona, M; Hartl, A; Hauser-Kronberger, C; Russe, E; Bieback, K; Rohde, E; Brachtl, G; Scharler, C; Strunk, D; Schallmoser, K
Vox Sanguinis. 2016; 111(Suppl. 1):285--34th International Congress of the ISBT ; 03.-08.09.2016; Dubai.
Abstracts (Zeitschrift)
Stepwise maturation of human iPS cells into clonogenic immunosuppressive mesenchymal stem/progenitor cells
Scharler, C; Ketterl, N; Hofler, M; Brachtl, G; Schallmoser, K; Strunk, D
HUM GENE THER. 2016; 27(11): A64-A64.
Abstracts (Zeitschrift)
DNA methylation mapping and computational modeling in a large Ewing sarcoma cohort identifies principles of tumor heterogeneity and their impact on clinical phenotypes
Sheffield, NC; Tirode, F; Grossetete-Lalami, S; Datlinger, P; Schonegger, A; Hadler, J; Walder, D; Ambros, IM; Amaral, AT; de Alava, E; Schallmoser, K; Strunk, D; Rinner, B; Liegl-Atzwanger, B; Huppertz, B; Leithner, A; Dirksen, U; Ambros, P; Delattre, O; Kovar, H; Bock, C; Tomazou, EM
CANCER RES. 2016; 76:
Abstracts (Zeitschrift)
Calcipotriol treatment enhances wound closure and antimicrobial defense in recessive dystrophic epidermolysis bullosa in vitro while inhibiting proliferation and clonogenicity of RDEB cancer cells.
Tockner, B; Scharler, C; Huttner, C; Zurl, A; Strunk, D; Bauer, JW; Reichelt, J; Lang, R; Gruber, C; Hofbauer, JP
MOL BIOL CELL. 2016; 27:
Abstracts (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Leukotriene receptor inhibition mobilizes human stem cells in vivo.
Brachtl, G; Hochreiter, A; Jacobs, VR; Schäfer, R; Strunk, D
4th Annual Meeting of the German Stem Cell Network (GSCN); 12.-14.09.2016; Hannover. 2016.
Leukotriene receptor inhibition mobilizes human stem cells in vivo.
Brachtl, G; Hochreiter, A; Jacobs, VR; Schäfer, R; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.
Leukotriene receptor inhibition mobilizes human stem cells in vivo.
Brachtl, G; Hochreiter, A; Schäfer, R; Strunk, D
3rd PACT-Symposium: Designer Cells Go Clinic; 23.-24.09.2016; Wien. 2016.
Effect of different cell culture conditions on the growth and clonogenicity of MSPCs.
Brachtl, G; Raninger, A; Hochreiter, A; Schäfer, R; Schallmoser, K; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Effect of different cell culture conditions on the growth and clonogenicity of MSPCs.
Brachtl, G; Raninger, A; Hochreiter, A; Schäfer, R; Schallmoser, K; Strunk, D
PMU Science Day; 24.06.2016; Salzburg. 2016.
Rolle von Mesenchymalen Stammzellen in der Organregeneration & Immunmodulation.
Brachtl, G; Strunk, D
20. Jahressymposium der IGLD; 25.-27.02.2016; Hamburg. 2016.
MSPCs from non-skeletal adult sources have an altered chondrogenic regeneration potency.
Hochmann, S; Scharler, C; Textor, M; Brachtl, G; Föttinger, P; Hochreiter, A; Geissler, S; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Understanding the molecular landscape of human bone marrow-derived mesenchymal stem/progenitor cells through meta-analysis.
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
4th Annual Meeting of the German Stem Cell Network (GSCN); 12.-14.09.2016; Hannover. 2016.
Understanding the molecular landscape of human BM-derived MSPCs through meta-analysis.
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Understanding the molecular landscape of human bone marrow-derived mesenchymal stem/progenitor cells through meta-analysis.
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Scharler, C; Schallmoser, K; Reinisch, A; Strunk, D
PMU Science Day; 24.06.2016; Salzburg. 2016.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Scharler, C; Schallmoser, K; Reinisch, A; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk, D
4th Annual Meeting of the German Stem Cell Network (GSCN); 12.-14.09.2016; Hannover. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Daheron, L; Brachtl, G; Schallmoser, K; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Daheron, L; Brachtl, G; Schallmoser, K; Strunk, D
3rd PACT-Symposium: Designer Cells Go Clinic; 23.-24.09.2016; Wien. 2016.
Mesenchymale Stammzelltherapie in der Autoimmunität
Strunk, D
Jahrestagung der Österreichischen Gesellschaft für Rheumatologie & Rehabilitation; 01.-03.12.2016; Wien. 2016.
Which Cells for What Clinical Application?
Strunk, D
PACT Symposium “Designer Cells Go Clinic”; 23.-24.09.2016; Wien. 2016.
Stammzelltherapie – Realität und Ausblick
Strunk, D
OEADF Akademie für Dermatologische Fortbildung 2016; 26.-28.05.2016; Wels. 2016.
Don’t get lost in translation: Which stem cells to use for what application?
Strunk, D
10th Annual UK Mesenchymal Stem Cell Meeting; 05.12.2016; York. 2016.

2015

Beiträge in Fachzeitschriften

Positive contrast of SPIO-labeled cells by off-resonant reconstruction of 3D radial half-echo bSSFP.
Diwoky, C; Liebmann, D; Neumayer, B; Reinisch, A; Knoll, F; Strunk, D; Stollberger, R;
NMR Biomed. 2015; 28(1):79-88
Originalarbeiten (Zeitschrift)
The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis.
Hofmann, NA; Yang, J; Trauger, SA; Nakayama, H; Huang, L; Strunk, D; Moses, MA; Klagsbrun, M; Bischoff, J; Graier, WF;
Br J Pharmacol. 2015; 172(16): 4107-4118.
Originalarbeiten (Zeitschrift)
A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance.
Ketterl, N; Brachtl, G; Schuh, C; Bieback, K; Schallmoser, K; Reinisch, A; Strunk, D;
Stem Cell Res Ther. 2015; 6: 236
Originalarbeiten (Zeitschrift)
Elevated levels of interleukin 17A and kynurenine in candidemic patients, compared with levels in noncandidemic patients in the intensive care unit and those in healthy controls.
Krause, R; Zollner-Schwetz, I; Salzer, HJ; Valentin, T; Rabensteiner, J; Prüller, F; Raggam, R; Meinitzer, A; Prattes, J; Rinner, B; Strohmaier, H; Quehenberger, F; Strunk, D; Heidrich, K; Buzina, W; Hoenigl, M;
J Infect Dis. 2015; 211(3):445-451
Originalarbeiten (Zeitschrift)
Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.
Lener, T; Gimona, M; Aigner, L; Börger, V; Buzas, E; Camussi, G; Chaput, N; Chatterjee, D; Court, FA; Del Portillo, HA; O"Driscoll, L; Fais, S; Falcon-Perez, JM; Felderhoff-Mueser, U; Fraile, L; Gho, YS; Görgens, A; Gupta, RC; Hendrix, A; Hermann, DM; Hill, AF; Hochberg, F; Horn, PA; de Kleijn, D; Kordelas, L; Kramer, BW; Krämer-Albers, EM; Laner-Plamberger, S; Laitinen, S; Leonardi, T; Lorenowicz, MJ; Lim, SK; Lötvall, J; Maguire, CA; Marcilla, A; Nazarenko, I; Ochiya, T; Patel, T; Pedersen, S; Pocsfalvi, G; Pluchino, S; Quesenberry, P; Reischl, IG; Rivera, FJ; Sanzenbacher, R; Schallmoser, K; Slaper-Cortenbach, I; Strunk, D; Tonn, T; Vader, P; van Balkom, BW; Wauben, M; Andaloussi, SE; Théry, C; Rohde, E; Giebel, B;
J Extracell Vesicles. 2015; 4: 30087
Originalarbeiten (Zeitschrift)
Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation.
Reinisch, A; Etchart, N; Thomas, D; Hofmann, NA; Fruehwirth, M; Sinha, S; Chan, CK; Senarath-Yapa, K; Seo, EY; Wearda, T; Hartwig, UF; Beham-Schmid, C; Trajanoski, S; Lin, Q; Wagner, W; Dullin, C; Alves, F; Andreeff, M; Weissman, IL; Longaker, MT; Schallmoser, K; Majeti, R; Strunk, D;
Blood. 2015; 125(2): 249-260.
Originalarbeiten (Zeitschrift)
Massive fistulization into the left ventricle of a transplanted heart.
Wallner, M; Zweiker, R; Maier, R; Strunk, D; von Lewinski, D;
Herz. 2015; 40(Supplement 1): 56-58.
Fallberichte

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Mesenchymal Stem Cells Differentiate into Osteoblasts in the Presence of AML Cells through Up-regulation of RUNX2 and Induce Chemo-resistance
Battula, VL; Le, PM; Sun, J; Mc Queen, T; Somanchi, A; Wang, RY; Strunk, D; Shpall, EJ; Ruvolo, P; Kantarjian, H; Konopleva, M; Andreeff, M
CL LYMPH MYELOM LEUK. 2015; 15: S185-S186.
Abstracts (Zeitschrift)
Allogeneic Stem Cell Transplantation In Patients With Acute Myeloid Leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)
Bohm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Wohrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Hauser, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B
CL LYMPH MYELOM LEUK. 2015; 15: S183-S183.
Abstracts (Zeitschrift)
Modifications of human platelet lysate for efficient expansion of mesenchymal stromal cells without fibrinogen.
Öller, M: Feichtner, M; Dunai, ZA; Raninger, A; Laner-Plamberger, S; Lener, T; Streif, D; Gimona, M; Hartl, A; Bieback, K; Wiedemann, H; Rohde, E; Strunk, D; Schallmoser, K
Transfus Med Hemother 2015;42(suppl1):p.63. 2015; -48.Jahrestagung der DGTI (Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie e.V.); 15. -18. 09.2015; Basel.
Abstracts (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Does Montelukast mobilize human stem/progenitor cells in vivo?.
Brachtl, G; Hochreiter, A; Strunk, D
2nd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 05.11.2015; Salzburg. 2015.
Cellular MRI through off-resonant reconstructions.
Diwoky, C; Liebmann, D; Reinisch, A; Strunk, D; Ropele, S; Stollberger, R
BioNanoMed2015, 6th International Congress Nanotechnology in Medicine & Biology; 08.-10.04.2015; Graz. 2015.
Identification of human bone marrow specific mesenchymal stem/progenitor cell (MSPC) gene expression signature through meta-analysis.
Kalathur, RK; Reinisch, A; Strunk, D
3rd International Annual Conference of the German Stem Cell Network (GSCN); 09.-11.09.2015; Frankfurt. 2015.
Comparing gene expression signatures of human mesenchymal stem/progenitor cells (MSPCs) from different organs using bioinformatic tools.
Kalathur, RK; Reinisch, A; Strunk D
World Conference on Regenerative Medicine 2015; 21.-23.10.2015; Leipzig. 2015.
Identification of human bone marrow specific mesenchymal stem/progenitor cell (MSPC) gene expression signature through meta-analysis.
Kalathur, RK; Reinisch, A; Strunk D
2nd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 05.11.2015; Salzburg. 2015.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
3rd International Annual Conference of the German Stem Cell Network (GSCN); 09.-11.09.2015; Frankfurt. 2015.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
World Conference on Regenerative Medicine 2015; 21.-23.10.2015; Leipzig. 2015.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
2nd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 05.11.2015; Salzburg. 2015.
Efficient animal serum-free propagation of mesenchymal stem cells by using fibrinogen-depleted modifications of human platelet lysate.
Öller, M; Feichtner, M; Dunai, ZA; Raninger, A; Laner-Plamberger, S; Lener, T; Gimona, M; Hartl, A; Bieback, K; Rohde, E; Strunk, D; Schallmoser, K
World Conference on Regenerative Medicine 2015; 21.-23.10.2015; Leipzig. 2015.
A novel humanized bone marrow niche xenotransplantation model allows superior engraftment of human normal and malignant hematopoietic cells and reveals myelofibrosis-initiating cells in the CD34+/CD38+/CD90+ compartment.
Reinisch, A; Strunk, D; Majeti, R
Keystone Symposium 2015 on Haematopoiesis; 22.-27.02.2015; Keystone, Colorado. 2015.
Optimizing conditions to differentiate human iPS cells into functional mesenchymal stem/progenitor cells.
Schuh, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk, D
3rd International Annual Conference of the German Stem Cell Network (GSCN); 09.-11.09.2015; Frankfurt. 2015.
Optimizing conditions to differentiate human iPS cells into functional mesenchymal stem/progenitor cells.
Schuh, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk D.
World Conference on Regenerative Medicine 2015; 21.-23.10.2015; Leipzig. 2015.
Attenuation of alloimmunity to human Endothelial Colony Forming Cells (ECFC) by interaction with Mesenchymal Stem/Progenitor Cells (MSPC) from umbilical cord.
Souidi, N; Rudeck, J; Stolk, M; Schmitt-Knosalla, I; Schuh, C; Schallmoser, K; Strunk, D; Volk, H-D; Seifert, M
3rd International Annual Conference of the German Stem Cell Network (GSCN); 09.-11.09.2015; Frankfurt. 2015.
Stem Cells in Regenerative Therapies - Overview
Strunk, D
3rd International Annual Conference of the German Stem Cell Network (GSCN); 03.-05.09.2015; Frankfurt. 2015.
Monitorisierung der immunmodulatorischen Kapazität von MSC in klinischen Studien.
Strunk, D
Hyperflow 2015, Meeting der Österreichischen Gesellschaft für Zytometrie; 17.-18.09.2015; Wien. 2015.
Advanced models in human stem cell transplantation
Strunk, D
Humunity Annual Meeting 2015; 21.-22.09.2015; Salzburg. 2015.
Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation.
Strunk, D; Schallmoser, K; Reinisch, A; Majeti, R
Keystone Symposium 2015 on Haematopoiesis; 22.-27.02.2015; Keystone, Colorado. 2015.

2014

Beiträge in Fachzeitschriften

TRPV1 mediates cellular uptake of anandamide and thus promotes endothelial cell proliferation and network-formation.
Hofmann, NA; Barth, S; Waldeck-Weiermair, M; Klec, C; Strunk, D; Malli, R; Graier, WF;
Biol Open. 2014; 3(12):1164-1172
Originalarbeiten (Zeitschrift)
Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance.
Jacamo, R; Chen, Y; Wang, Z; Ma, W; Zhang, M; Spaeth, EL; Wang, Y; Battula, VL; Mak, PY; Schallmoser, K; Ruvolo, P; Schober, WD; Shpall, EJ; Nguyen, MH; Strunk, D; Bueso-Ramos, CE; Konoplev, S; Davis, RE; Konopleva, M; Andreeff, M;
Blood. 2014; 123(17): 2691-2702.
Originalarbeiten (Zeitschrift)
Mesenchymal stromal cells from the human placenta promote neovascularization in a mouse model in vivo.
Kinzer, M; Hingerl, K; Konig, J; Reinisch, A; Strunk, D; Huppertz, B; Lang, I
PLACENTA. 2014; 35(7): 517-519.
Originalarbeiten (Zeitschrift)
Effects of directly autotransplanted tibial bone marrow aspirates on bone regeneration and osseointegration of dental implants.
Payer, M; Lohberger, B; Strunk, D; Reich, KM; Acham, S; Jakse, N;
Clin Oral Implants Res. 2014; 25(4): 468-474.
Originalarbeiten (Zeitschrift)
Impact of autogenous concentrated bone marrow aspirate on bone regeneration after sinus floor augmentation with a bovine bone substitute--a split-mouth pilot study.
Wildburger, A; Payer, M; Jakse, N; Strunk, D; Etchard-Liechtenstein, N; Sauerbier, S
Clin Oral Implants Res. 2014; 25(10):1175-1181
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Acute Myeloid Leukemia Cells Acquire Chemo-Resistance By Inducing Osteoblast Differentiation in Mesenchymal Stem Cells through up-Regulation of RUNX2
Battula, VL; Le, PM; Sun, J; McQueen, T; Somanchi, A; Wang, RY; Strunk, D; Shpall, EJ; Ruvolo, PP; Kantarjian, HM; Konopleva, M; Andreeff, M
BLOOD. 2014; 124(21):
Abstracts (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Acute myeloid leukemia cells acquire chemo-resistance by inducing osteoblast differentiation in mesenchymal stem cells through up-regulation of RUNX2.
Battula, VL; Le, PM; Sun, J; McQueen, T; Somanchi, A; Wang, R-W; Strunk, D; Shpall, EJ; Ruvolo, PP; Kantarjian, HM; Konopleva; Andreeff, M
56th AHS Annual Meeting and Exposition; 06.-09.12.2014; San Francisco. 2014.
U-derived stem/progenitor cells: A noninvasice cell source for regenerative purposes.
Brachtl, G; Schuh, C; Ketterl, N; Höfler, M; Strunk, D
2nd International Annual Conference of the German Stem Cell Network (GSCN); 03.-05.11.2014; Heidelberg. 2014.
U-derived stem/progenitor cells: A noninvasice cell source for regenerative purposes.
Brachtl, G; Schuh, C; Ketterl, N; Höfler, M; Strunk, D
1st Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 13.11.2014; Salzburg. 2014.
Optimizing conditions to differentiate human induced pluripotent stem cells into mesenchymal stem/progenitor cells.
Höfler, M; Schuh, C; Ketterl, N; Brachtl, G; Strunk, D
International Annual Conference of the German Stem Cell Network (GSCN); 03.-05.11.2014; Heidelberg. 2014.
Expression of nucleotide oligomerization domain like receptors in human mesencyhmal stem cells.
Jetzinger, A; Ackaert, C; Duschl, A; Strunk, D; Horejs-Hoeck, J
6th ÖGMBT Annual Meeting; 15.-18.09.2014; Wien. 2014.
Analyzing the immune modulation potential of human mesenchymal stem/progenitor cells.
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
1st Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 13.11.2014; Salzburg. 2014. ; 13.11.2014; Salzburg. 2014.
Predicting and optimizing the immune modulation potential of human mesenchymal stem/progenitor cells.
Ketterl, N; Brachtl, G, Schuh, C; Schallmoser, K; Strunk, D
2nd International Annual Conference of the German Stem Cell Network (GSCN); 03.-05.11.2014; Heidelberg. 2014.
Optimizing conditions to differentiate human iPS cells into functional mesenchymal stem/progenitor cells.
Schuh, C; Höfler, M; Ketterl, N; Brachtl, G; Strunk, D
1st Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 13.11.2014; Salzburg. 2014.
Mesenchymal stem/progenitor cell function: Beyond regeneration.
Strunk, D
Foundation Symposium of the platform for advanced cellular therapies (PACT); 04.04.2014; Wien. 2014.
First do no harm: Translation of regenerative stem cell therapies.
Strunk, D
109th Annual Meeting of the Anatomische Gesellschaft; 25.09.2014; Salzburg. 2014.

2013

Beiträge in Fachzeitschriften

Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment.
Battula, VL; Chen, Y; Cabreira, MD; Ruvolo, V; Wang, ZQ; Ma, WC; Konoplev, S; Shpall, E; Lyons, K; Strunk, D; Bueso-Ramos, C; Davis, RE; Konopleva, M; Andreeff, M
Blood. 2013; 122(3):357-366
Originalarbeiten (Zeitschrift)
Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma.
Deutsch, AJA; Steinbauer, E; Hofmann, NA; Strunk, D; Gerlza, T; Beham-Schmid, C; Schaider, H; Neumeister, P
MODERN PATHOL. 2013; 26(2): 182-194.
Originalarbeiten (Zeitschrift)
Donor selection and release criteria of cellular therapy products.
Eichler, H; Schrezenmeier, H; Schallmoser, K; Strunk, D; Nystedt, J; Kaartinen, T; Korhonen, M; Fleury-Cappellesso, S; Sensebé, L; Bönig, H; Rebulla, P; Giordano, R; Lecchi, L; Takanashi, M; Watt, SM; Austin, EB; Guttridge, M; McLaughlin, LS; Panzer, S; Reesink, HW;
Vox Sang. 2013; 104(1): 67-91.
Originalarbeiten (Zeitschrift)
Tri-lineage potential of intraoral tissue-derived mesenchymal stromal cells.
Lohberger, B; Payer, M; Rinner, B; Kaltenegger, H; Wolf, E; Schallmoser, K; Strunk, D; Rohde, E; Berghold, A; Pekovits, K; Wildburger, A; Leithner, A; Windhager, R; Jakse, N;
J Craniomaxillofac Surg. 2013; 41(2):110-118
Originalarbeiten (Zeitschrift)
Identification of an Effective Early Signaling Signature during Neo-Vasculogenesis In Vivo by Ex Vivo Proteomic Profiling
Rohban, R; Reinisch, A; Etchart, N; Schallmoser, K; Hofmann, NA; Szoke, K; Brinchmann, JE; Rad, EB; Rohde, E; Strunk, D
PLOS ONE. 2013; 8(6): e66909
Originalarbeiten (Zeitschrift)
Generation of a pool of human platelet lysate and efficient use in cell culture.
Schallmoser, K; Strunk, D;
Methods Mol Biol. 2013; 946:349-362
Originalarbeiten (Zeitschrift)
A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies.
Warnke, PH; Humpe, A; Strunk, D; Stephens, S; Warnke, F; Wiltfang, J; Schallmoser, K; Alamein, M; Bourke, R; Heiner, P; Liu, Q;
J Craniomaxillofac Surg. 2013; 41(2):153-161
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Allogeneic stem cell transplantation in patients with acute myeloid leukaemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)
Boehm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Woehrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Hauser, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B
BONE MARROW TRANSPL. 2013; 48: S393-S393.
Abstracts (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Mesenchymale und Endotheliale Stammzellen in der Regenerativen Medizin.
Strunk, D
Stammzelltag der BioCity Leipzig; 07.06.2013; Leipzig. 2013.
Zelltherapie im Rahmen der regenerativen Medizin
Strunk, D
Gewebebank–Symposium der Medizinischen Universität Wien; 20.06.2013; Wien. 2013.

2012

Beiträge in Fachzeitschriften

Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation.
Ansari, M; Strunk, D; Schallmoser, K; Delcò, C; Rougemont, AL; Moll, S; Villard, J; Gumy-Pause, F; Chalandon, Y; Parvex, P; Passweg, J; Ozsahin, H; Kindler, V;
Pediatr Transplant. 2012; 16(2):131-136
Originalarbeiten (Zeitschrift)
Human extramedullary bone marrow in mice: a novel in vivo model of genetically controlled hematopoietic microenvironment.
Chen, Y; Jacamo, R; Shi, YX; Wang, RY; Battula, VL; Konoplev, S; Strunk, D; Hofmann, NA; Reinisch, A; Konopleva, M; Andreeff, M
BLOOD. 2012; 119(21): 4971-4980.
Originalarbeiten (Zeitschrift)
Oxygen sensing mesenchymal progenitors promote neo-vasculogenesis in a humanized mouse model in vivo.
Hofmann, NA; Ortner, A; Jacamo, RO; Reinisch, A; Schallmoser, K; Rohban, R; Etchart, N; Fruehwirth, M; Beham-Schmid, C; Andreeff, M; Strunk, D;
PLoS One. 2012; 7(9):e44468
Originalarbeiten (Zeitschrift)
Endothelial colony-forming progenitor cell isolation and expansion.
Hofmann, NA; Reinisch, A; Strunk, D;
Methods Mol Biol. 2012; 879: 381-387.
Originalarbeiten (Zeitschrift)
Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodium iodide symporter transgene expression.
Templin, C; Zweigerdt, R; Schwanke, K; Olmer, R; Ghadri, JR; Emmert, MY; Muller, E; Kuest, SM; Cohrs, S; Schibli, R; Kronen, P; Hilbe, M; Reinisch, A; Strunk, D; Haverich, A; Hoerstrup, S; Luscher, TF; Kaufmann, PA; Landmesser, U; Martin, U
CIRCULATION. 2012; 126(4): 430-439.
Originalarbeiten (Zeitschrift)
Human dermis harbors distinct mesenchymal stromal cell subsets.
Vaculik, C; Schuster, C; Bauer, W; Iram, N; Pfisterer, K; Kramer, G; Reinisch, A; Strunk, D; Elbe-Burger, A
J INVEST DERMATOL. 2012; 132(3 Pt 1): 563-574.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Platelet-derived factors preserve human mesenchymal cell stemness and promote endochondral bone and marrow niche formation via PDGF-receptor signalling
Etchart, N; Reinisch, A; Ortner, A; Fruhwirth, M; Hofmann, N; Rohban, R; Url, C; Schallmoser, K; Beham-Schmid, C; Strunk, D
BONE MARROW TRANSPL. 2012; 47: S49-S50.
Abstracts (Zeitschrift)
Collagen receptor-mediated mechanochemical signalling modulates human pro-angiogenic mesenchymal stem/progenitor cells during neovascularisation
Gimona, M; Rohban, R; Lener, T; Oller, M; Schallmoser, K; Strunk, D; Rohde, E
BONE MARROW TRANSPL. 2012; 47: S317-S317.
Abstracts (Zeitschrift)
Collagen Receptor-Mediated Mechanochemical Signaling Contributes to Human Pro-Angiogenic Mesenchymal Stem/Progenitor Cell-Induced Neo-Vasculogenesis
Gimona, M; Rohban, R; Lener, T; Peckl-Schmid, D; Oeller, M; Schallmoser, K; Strunk, D; Rohde, E
BLOOD. 2012; 120(21):
Abstracts (Zeitschrift)
Therapeutic neo-vasculogenesis in vivo is promoted by oxygen sensing mesenchymal stem/progenitor cells
Hofmann, NA; Ortner, A; Jacamo, RO; Reinisch, A; Etchart, N; Schallmoser, K; Fruehwirth, M; Rohban, R; Beham-Schmid, C; Andreeff, M; Strunk, D
BONE MARROW TRANSPL. 2012; 47: S319-S320.
Abstracts (Zeitschrift)
Organotypic Epigenetic Signature Predicts Bone and Marrow Niche Forming Capacity of Stromal Progenitors in a Novel Mouse Model in Vivo
Reinisch, A; Etchart, N; Hofmann, NA; Fruhwirth, M; Ortner, A; Thaler, D; Feilhauer, B; Hartwig, UF; Beham-Schmid, C; Trajanosky, S; Wagner, W; Alves, F; Schallmoser, K; Andreeff, M; Strunk, D
BLOOD. 2012; 120(21):
Abstracts (Zeitschrift)
Bone and haematopoietic niche formation is predetermined by a specific epigenetic signature
Reinisch, A; Etchart, N; Hofmann, NA; Fruhwirth, M; Thaler, D; Feilhauer, B; Ortner, A; Beham-Schmid, C; Trajanoski, S; Wagner, W; Schallmoser, K; Strunk, D
BONE MARROW TRANSPL. 2012; 47: S48-S49.
Abstracts (Zeitschrift)
Early in vivo signalling signature during human stem/progenitor cell-derived neo-vasculogenesis
Rohban, R; Etchart, N; Reinisch, A; Hofmann, N; Thaler, D; Feilhauer, B; Dacheva, M; Schallmoser, K; Rohde, E; Strunk, D
BONE MARROW TRANSPL. 2012; 47: S49-S49.
Abstracts (Zeitschrift)
Maintenance of Osteogenic Differentiation Capacity of MSPC Despite Amplified Proliferation Under Elevated Oxgen Conditions
Schallmoser, K; Hofmann, NA; Reinisch, A; Ortner, A; Url, C; Etchart, N; Joussen, S; Wagner, W; Strunk, D
BLOOD. 2012; 120(21):
Abstracts (Zeitschrift)
Elevated oxygen environment boosts MSPC proliferation without senescence aggravation
Schallmoser, K; Ortner, A; Hofmann, NA; Etchart, N; Joussen, S; Url, C; Wagner, W; Strunk, D
BONE MARROW TRANSPL. 2012; 47: S319-S319.
Abstracts (Zeitschrift)
Evaluating immunogenicity of human endothelial colony forming cells for application in cell-based therapies
Souidi, N; Schallmoser, K; Strunk, D; Schmidt-Lucke, C; Volk, HD; Seifert, M
J TISSUE ENG REGEN M. 2012; 6: 247-247.
Abstracts (Zeitschrift)
Xeno-free culturing of human muscle precursor cells (MPC) for clinical application
Zouraq, FA; Salemi, S; Largo, RA; Schallmoser, K; Strunk, D; Susler, T; Eberli, D
J TISSUE ENG REGEN M. 2012; 6: 132-132.
Abstracts (Zeitschrift)

Originalbeiträge in Sammelwerk (Buchbeitrag)

Animal Protein-free Expansion of Human Mesenchymal Stem/progenitor Cells.
Schallmoser, K; Etchart, N; Strunk, D; Rohde, E;
In: Allen, DS; Strunk, D (Ed.) editors(s). Regenerative Therapy Using Blood-Derived Stem cells.. p. 53-70.

2011

Beiträge in Fachzeitschriften

Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions.
Almer, G; Saba-Lepek, M; Haj-Yahya, S; Rohde, E; Strunk, D; Fröhlich, E; Prassl, R; Mangge, H;
Biologics. 2011; 5: 9-105.
Originalarbeiten (Zeitschrift)
Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing"s sarcoma.
Ban, J; Jug, G; Mestdagh, P; Schwentner, R; Kauer, M; Aryee, DNT; Schaefer, KL; Nakatani, F; Scotlandi, K; Reiter, M; Strunk, D; Speleman, F; Vandesompele, J; Kovar, H
ONCOGENE. 2011; 30(18): 2173-2180.
Originalarbeiten (Zeitschrift)
Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate.
Flemming, A; Schallmoser, K; Strunk, D; Stolk, M; Volk, HD; Seifert, M;
J Clin Immunol. 2011; 31(6): 1143-1156.
Originalarbeiten (Zeitschrift)
Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation.
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Fröhlich, E; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D;
CYTOTHERAPY. 2011; 13(4): 503-512.
Originalarbeiten (Zeitschrift)
Endothelial progenitor cells: quod erat demonstrandum?
Strunk, D
CURR PHARM DESIGN. 2011; 17(30): 324-351.
Übersichtsarbeiten
Thiolated polyacrylic acid-modified iron oxide nanoparticles for in vitro labeling and MRI of stem cells.
Vetter, A; Reinisch, A; Strunk, D; Kremser, C; Hahn, HW; Huck, CW; Ostermann, T; Leithner, K; Bernkop-Schnurch, A
J DRUG TARGET. 2011; 19(7): 56-72.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Human Extramedullary Bone and Bone Marrow in Mice: First In Vivo Model of a Genetically Controlled Hematopoietic Environment
Chen, Y; Jacamo, RO; Hofmann, NA; Shi, YX; Wang, RY; Konoplev, S; Strunk, D; Konopleva, M; Andreeff, M
BLOOD. 2011; 118(21): 584-584.
Abstracts (Zeitschrift)
Human platelet-derived factors maintain a bone and marrow niche-competent function of mesenchymal stem/progenitor cells
Etchart, N; Reinisch, A; Gungl, D; Hofmann, NA; Rohban, R; Ortner, A; Rankl, J; Hofmeister, A; Beham-Schmid, C; Schallmoser, K; Strunk, D
BONE MARROW TRANSPL. 2011; 46: S303-S303.
Abstracts (Zeitschrift)
Platelet-Derived Factors Allow Human Mesenchymal Stem Cells to Spontaneously Undergo Endochondral Bone Differentiation and Provide Bone Marrow Support in a Xenogenic In Vivo Model
Etchart, N; Reinisch, A; Ortner, A; Fruhwirth, M; Rohban, R; Url, C; Schallmoser, K; Beham-Schmid, C; Strunk, D
BLOOD. 2011; 118(21): 583-584.
Abstracts (Zeitschrift)
Neo-Vasculogenesis In Vivo Is Facilitated by Oxygen Sensing Mesenchymal Stem and Pogenitor Cells
Hofmann, NA; Ortner, A; Jacamo, RO; Reinisch, A; Schallmoser, K; Fruewirth, M; Diwoky, C; Rohban, R; Beham-Schmid, C; Andreeff, M; Strunk, D
BLOOD. 2011; 118(21): 319-319.
Abstracts (Zeitschrift)
Vascular regeneration in vivo is promoted by oxygen sensing mesenchymal stem and progenitor cells
Hofmann, NA; Reinisch, A; Ortner, A; Etchart, N; Schallmoser, K; Absenger, M; Strunk, D
BONE MARROW TRANSPL. 2011; 46: S302-S302.
Abstracts (Zeitschrift)
UCBT with low-dose ATG in adults
Linkesch, W; Neumeister, P; Zinke-Cerwenka, W; Strunk, D; Sill, H
BONE MARROW TRANSPL. 2011; 46: S128-S129.
Abstracts (Zeitschrift)
Results of UCBT with ATG in adults
Linkesch, W; Sill, H; Zinke-Cerwenka, W; Neumeister, P; Strunk, D
ONKOLOGIE. 2011; 34: 271-271.
Abstracts (Zeitschrift)
Human dermal-derived interfollicular mesenchymal stem cells drive the differentiation of naive helper T cells towards a regulatory phenotype without provision of costimulatory molecules
Pfisterer, K; Vaculik, C; Kramer, C; Strunk, D; Elbe-Burger, A
J INVEST DERMATOL. 2011; 131: S97-S97.
Abstracts (Zeitschrift)
Unexpected somatic restriction of mesenchymal stem and progenitor cells after transplantation in vivo
Reinisch, A; Etchart, N; Hofmann, NA; Gungl, D; Ortner, A; Rankl, J; Beham-Schmid, C; Schallmoser, K; Strunk, D
BONE MARROW TRANSPL. 2011; 46: S302-S303.
Abstracts (Zeitschrift)
Dissociation of In Vivo and in Vitro Differentiation Capacity of Human Mesenchymal Stem Cells Is Reflected by a Tissue Specific Epigenetic Memory
Reinsch, A; Liechtenstein, N; Hofmann, NA; Ortner, A; Fruhwirth, M; Schallmoser, K; Beham-Schmid, C; Strunk, D
BLOOD. 2011; 118(21): 1027-1028.
Abstracts (Zeitschrift)
Identification of early in vivo signalling signature during regenerative stem cell therapy using proteomic profiling
Rohban, R; Reinisch, A; Rohde, E; Hofmann, NA; Gimona, M; Etchart, N; Ortner, A; Strunk, D
BONE MARROW TRANSPL. 2011; 46: S50-S50.
Abstracts (Zeitschrift)

2010

Beiträge in Fachzeitschriften

A case of generalized MALT lymphoma with IgM paraproteinemia and peripheral blood involvement.
Reitter, S; Neumeister, P; Beham-Schmid, C; Emberger, W; Strunk, D; Brezinschek, R; Linkesch, W; Schmidt, HH
ANN HEMATOL. 2010; 89(2): 213-214.
Letter
Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions.
Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Horn, P; Ho, AD; Strunk, D; Wagner, W;
HAEMATOL-HEMATOL J. 2010; 95(6): 86-74.
Originalarbeiten (Zeitschrift)
Prevention of oxidative stress in porcine islet isolation.
Stiegler, P; Stadlbauer, V; Hackl, F; Schaffellner, S; Iberer, F; Greilberger, J; Strunk, D; Zelzer, S; Lackner, C; Tscheliessnigg, K
J ARTIF ORGANS. 2010; 13(1): 38-47.
Originalarbeiten (Zeitschrift)
How to track cellular aging of mesenchymal stromal cells?
Wagner, W; Bork, S; Lepperdinger, G; Joussen, S; Ma, N; Strunk, D; Koch, C
AGING-US. 2010; 2(4): 224-230.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

HYPOXIA MAINTAINS STEMNESS OF ENDOTHELIAL PROGENITOR CELLS
Hofmann, N; Reinisch, A; Schallmoser, K; Rohde, E; Absenger, M; Birner-Gruenberger, R; Strunk, D
HAEMATOL-HEMATOL J. 2010; 95: 97-97.
Abstracts (Zeitschrift)
Oxygen Sensing of Mesenchymal Stem and Progenitor Cells Facilitates Neo-Vasculogenesis In Vivo.
Hofmann, NA; Reinisch, A; Ortner, A; Schallmoser, K; Rohde, E; Absenger, M; Birner-Gruenberger, R; Strunk, D
BLOOD. 2010; 116(21): 1750-1750.
Abstracts (Zeitschrift)
Hypoxia maintains stemness of somatic endothelial colony forming progenitor cells
Hofmann, NA; Reinisch, A; Schallmoser, K; Rohde, E; Chatterjee, S; Absenger, M; Birner-Gruenberger, R; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S279-S279.
Abstracts (Zeitschrift)
Long-term follow-up of minimal chronic graft-versus-host disease after reduced-intensity conditioning with pre-transplant low dose anti-thymocyte globulin in allogeneic stem cell transplantation
Langner, S; Staber, P; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S145-S145.
Abstracts (Zeitschrift)
Human Vascular Progenitor Cells Can Guide Mesodermal Lineage Choice of Mesenchymal Stem and Progenitor Cells After Co-Transplantation In Vivo
Reinisch, A; Etchart, N; Hofmann, NA; Ortner, A; Rohde, E; Schallmoser, K; Beham-Schmid, C; Dullin, C; Diwoky, C; Hofmeister, A; Stollberger, R; Alves, F; Strunk, D
BLOOD. 2010; 116(21): 414-415.
Abstracts (Zeitschrift)
STABLE VESSEL GENERATION TROUGH APPLICATION OF BLOOD-DERIVED ENDOTHELIAL COLONY FORMING PROGENITOR CELLS (ECFCS) AND MESENCHYMAL STROMAL/STEM CELLS (MSCS)
Reinisch, A; Hofmann, N; Obenauf, A; Karl, K; Rohde, E; Schallmoser, K; Thaler, D; Fruhwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D
HAEMATOL-HEMATOL J. 2010; 95: 208-208.
Abstracts (Zeitschrift)
VASCULAR PROGENITOR CELLS CAN INSTRUCT DEVELOPMENTAL FATE DECISION OF CD146(+) MESENCHYMAL STROMAL/STEM CELLS IN VIVO
Reinisch, A; Hofmann, N; Ortner, A; Etchart, N; Beham-Schmid, C; Dullin, C; Diwoky, C; Hofmeister, A; Stollberger, R; Alves, F; Strunk, D
HAEMATOL-HEMATOL J. 2010; 95: 479-479.
Abstracts (Zeitschrift)
Sustained vessel formation through co-transplantation of endothelial colony-forming progenitor cells with mesenchymal stromal cells
Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruhwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S52-S52.
Abstracts (Zeitschrift)
Vascular progenitor cells can instruct skeletal stem cells during developmental fate decisions
Reinisch, A; Hofmann, NA; Ortner, A; Etchart, N; Beham-Schmidt, C; Dullin, C; Diwoky, C; Hofmeister, A; Stollberger, R; Alves, F; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S53-S53.
Abstracts (Zeitschrift)
BLOOD AND MARROW-DERIVED PROGENITORS ARE SUSCEPTIBLE TO MAPK P38-DEPENDENT FOAM CELL INDUCTION
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, N; Pfeifer, T; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D
HAEMATOL-HEMATOL J. 2010; 95: 436-436.
Abstracts (Zeitschrift)
THERAPEUTIC ANGIOGENESIS WITH CELLULAR THERAPY: PRO-ANGIOGENIC INDUCTION OF MYELOID CELLS CAN FAVOR MAPK P38-DEPENDENT FOAM CELL DEVELOPMENT
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Lanzer, G; Strunk, D
VOX SANG. 2010; 99: 20-20.
Abstracts (Zeitschrift)
MAPK p38-dependent foam cell formation of myeloid cells after pro-angiogenic induction as a risk factor of therapeutic angiogenesis
Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Rechberger, G; Lanzer, G; Linkesch, W; Kratky, D; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S283-S283.
Abstracts (Zeitschrift)
SENESCENCE-ASSOCIATED GENE EXPRESSION CHANGES IN MESENCHYMAL STROMAL/STEM CELLS
Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, A; Reinisch, A; Horn, P; Ho, A; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D
HAEMATOL-HEMATOL J. 2010; 95: 98-98.
Abstracts (Zeitschrift)
Replicative senescence-associated gene expression changes in mesenchymal stromal cells
Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Hom, P; Ho, AD; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S281-S281.
Abstracts (Zeitschrift)
SIMILARITY OF REPLICATIVE SENESCENCE-ASSOCIATED GENE EXPRESSION CHANGES IN MESENCHYMAL STROMAL CELLS UNDER VARIOUS CULTURE CONDITIONS
Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Horn, P; Ho, AD; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D
VOX SANG. 2010; 99: 481-482.
Abstracts (Zeitschrift)
Genomic Stability of Mesenchymal Stromal/Stem Cells After Long-Term Culture
Schallmoser, K; Rohde, E; Obenauf, AC; Reinisch, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
TRANSFUSION. 2010; 50: 24A-24A.
Abstracts (Zeitschrift)
GENOMIC STABILITY IN LONG-TERM CULTURED MESENCHYMAL STROMAL/STEM CELLS
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
HAEMATOL-HEMATOL J. 2010; 95: 97-97.
Abstracts (Zeitschrift)
Alteration of genomic stability in long-term cultured mesenchymal stromal cells
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S280-S280.
Abstracts (Zeitschrift)
ENDOTHELIAL COLONY-FORMING CELL OUTGROWTH IS CORRELATED WITH INTIMA MEDIA THICKNESS AND CARDIOVASCULAR RISK FACTORS IN TYPE 2 DIABETIC PATIENTS
Sourij, H; Hofmann, NA; Tripolt, N; Reinisch, A; Eder, M; Pieber, TR; Strunk, D
ATHEROSCLEROSIS SUPP. 2010; 11(2): 141-141.
Abstracts (Zeitschrift)
Combined action of endothelial and mesenchymal niche cells to amplify haematopoietic progenitor expansion in a humanized system
Thaler, D; Fruthwirth, M; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Hartwig, U; Strunk, D
BONE MARROW TRANSPL. 2010; 45: S53-S53.
Abstracts (Zeitschrift)

2009

Beiträge in Fachzeitschriften

Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.
Bieback, K; Hecker, A; Kocaömer, A; Lannert, H; Schallmoser, K; Strunk, D; Klüter, H;
Stem Cells. 2009; 27(9): 233-241.
Originalarbeiten (Zeitschrift)
Isolation and large scale expansion of adult human endothelial colony forming progenitor cells.
Hofmann, NA; Reinisch, A; Strunk, D;
J Vis Exp. 2009;
Originalarbeiten (Zeitschrift)
IFPA meeting 2008 workshops report.
Lash, GE; Ansari, T; Bischof, P; Burton, GJ; Chamley, L; Crocker, I; Dantzer, V; Desoye, G; Drewlo, S; Fazleabas, A; Jansson, T; Keating, S; Kliman, HJ; Lang, I; Mayhew, T; Meiri, H; Miller, RK; Nelson, DM; Pfarrer, C; Roberts, C; Sammar, M; Sharma, S; Shiverick, K; Strunk, D; Turner, MA; Huppertz, B
PLACENTA. 2009; 30 Suppl A: S-14.
Übersichtsarbeiten
Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo.
Reinisch, A; Hofmann, NA; Obenauf, AC; Kashofer, K; Rohde, E; Schallmoser, K; Flicker, K; Lanzer, G; Linkesch, W; Speicher, MR; Strunk, D;
Blood. 2009; 113(26): 6716-6725.
Originalarbeiten (Zeitschrift)
Isolation and animal serum free expansion of human umbilical cord derived mesenchymal stromal cells (MSCs) and endothelial colony forming progenitor cells (ECFCs).
Reinisch, A; Strunk, D;
J Vis Exp. 2009; (32):
Originalarbeiten (Zeitschrift)
Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany.
Schafer, R; Dominici, M; Muller, I; Horwitz, E; Asahara, T; Bulte, JWM; Bieback, K; Le Blanc, K; Buhring, HJ; Capogrossi, MC; Dazzi, F; Gorodetsky, R; Henschler, R; Handgretinger, R; Kajstura, J; Kluger, PJ; Lange, C; von Luettichau, I; Mertsching, H; Schrezenmeier, H; Sievert, KD; Strunk, D; Verfaillie, C; Northoff, H
CYTOTHERAPY. 2009; 11(2): 245-255.
Übersichtsarbeiten
The particle gel immunoassay as a rapid test to rule out heparin-induced thrombocytopenia?
Schallmoser, K; Drexler, C; Rohde, E; Strunk, D; Groselj-Strele, A; Lanzer, G; Kroll, H; Panzer, S;
J Thorac Cardiovasc Surg. 2009; 137(3): 781-783.
Editorials
Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells.
Schallmoser, K; Rohde, E; Bartmann, C; Obenauf, AC; Reinisch, A; Strunk, D;
Biomed Mater Eng. 2009; 19(4-5): 271-276.
Originalarbeiten (Zeitschrift)
Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures.
Schallmoser, K; Strunk, D;
J Vis Exp. 2009; (32):
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Impact of mesenchymal stem cell transfusion on thrombotic microangiopathy post haematopoietic stem cell transplantation
Ansari, M; Kindler, V; Delco, C; Salah, V; Chalandon, Y; Gumy-Pause, F; Rougemont, A; Moll, S; Parvex, P; Chehade, H; Strunk, D; Passweg, J; Ozsahin, H
BONE MARROW TRANSPL. 2009; 43: S193-S193.
Abstracts (Zeitschrift)
Contribution of endothelial and mesenchymal niche cells to haematopoietic progenitor expansion in a humanised system
Fruehwirth, M; Thaler, D; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2009; 43: S188-S189.
Abstracts (Zeitschrift)
Porcine islet cell isolation for xenotransplantation: an optimized method with minimized oxidative stress for the PIC
Koestenbauer, S; Stiegler, P; Stadlbauer-Kollner, V; Schaffellner, S; Iberer, F; Greilberger, J; Strunk, D; Lackner, K; Hackl, F; Zelzer, S; Tscheliesnigg, K
HUM GENE THER. 2009; 20(11): 1480-1480.
Abstracts (Zeitschrift)
Vascular regeneration by adult blood-derived endothelial colony-forming cells expanded under animal serum-free conditions
Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D
BONE MARROW TRANSPL. 2009; 43: S19-S20.
Abstracts (Zeitschrift)
Pro-atherogenic risk of cellular therapy for vascular regeneration?
Rohde, E; Pfeifer, T; Schallmoser, K; Reinisch, A; Hofmann, NA; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Strunk, D
BONE MARROW TRANSPL. 2009; 43: S203-S204.
Abstracts (Zeitschrift)
Evidence for genomic stability of bone marrow-derived MSCS after large-scale expansion in a humanised system
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2009; 43: S187-S187.
Abstracts (Zeitschrift)

2008

Beiträge in Fachzeitschriften

Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells.
Bieback, K; Schallmoser, K; Klutera, H; Strunk, D
TRANSFUS MED HEMOTH. 2008; 35(4): 286-294.
Originalarbeiten (Zeitschrift)
Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum.
Schallmoser, K; Rohde, E; Reinisch, A; Bartmann, C; Thaler, D; Drexler, C; Obenauf, AC; Lanzer, G; Linkesch, W; Strunk, D;
Tissue Eng Part C Methods. 2008; 14(3):185-196
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Combined Action of Endothelial and Mesenchymal Niche Cells to Amplify Hematopoietic Progenitor Expansion in a Humanized System
Frohwirth, M; Thaler, D; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Strunk, D
BLOOD. 2008; 112(11): 840-840.
Abstracts (Zeitschrift)
Human platelet-derived factors regulate gene expression profile and function of human multipotent mesenchymal stromal cells
Reinisch, A; Bartmann, C; Schallmoser, K; Rohde, E; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2008; 41: S128-S129.
Abstracts (Zeitschrift)
Molecular imaging of bone marrow stromal cells
Reinisch, A; Diwoky, C; Hofmann, N; Schallmoser, K; Linkesch, W; Stollberger, R; Strunk, D
BONE MARROW TRANSPL. 2008; 41: S432-S432.
Abstracts (Zeitschrift)
Making Functional Endothelial Progenitors: Humanized Large-Scale Animal Serum-Free Propagated Adult Blood-Derived Endothelial Colony-Forming Cells Assemble Stable Perfused Vessels in Vivo
Reinisch, A; Hofmann, NA; Obenauf, HC; Kashofer, K; Rohde, E; Thaler, D; Friihwirth, M; Linkesch, W; Speicher, MR; Strunk, D
BLOOD. 2008; 112(11): 659-659.
Abstracts (Zeitschrift)
Combating Cardiovascular Disease: Is There a Risk of Foam Cell Formation in Trahsplanted Angiocompetent Cells Compromising Intended Beneficial Effects of Vascular Regenerative Therapy?.
Rohde, E; Aflaki, E; Froehlich, E; Lanzer, G; Kratky, D; Strunk, D
BLOOD. 2008; 112(11): 665-666.
Abstracts (Zeitschrift)
Excluding HIT Diagnosis by a Particle Gel Immunoassay
Schallmoser, K; Drexler, C; Rohde, E; Strunk, D; Groselj-Strele, A; Lanzer, G; Kroll, H; Panzer, S
BLOOD. 2008; 112(11): 1168-1168.
Abstracts (Zeitschrift)
Minimum requirements for fully humanised clinical scale propagation of multipotent mesenchymal stromal cells
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Speicher, M; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2008; 41: S314-S314.
Abstracts (Zeitschrift)
Genomic Stability and Safety of MSCs after Animal Serum-Free Humanized Clinical Scale Propagation
Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D
BLOOD. 2008; 112(11): 805-805.
Abstracts (Zeitschrift)

Originalbeiträge in Sammelwerk (Buchbeitrag)

GMP-Compliant Propagation of Human Multipotent Mesenchymal Stromal Cells
Rohde, E; Schallmoser, K; Bartmann, C; Reinisch, A;Strunk D
In: Gad, SC editors(s). Pharmaceutical Manufacturing Handbook: Regulations and Quality . John Wiley & Sons, Inc. ; p. 97-115.

2007

Beiträge in Fachzeitschriften

Two steps to functional mesenchymal stromal cells for clinical application.
Bartmann, C; Rohde, E; Schallmoser, K; Pürstner, P; Lanzer, G; Linkesch, W; Strunk, D;
Transfusion. 2007; 47(8): 1426-1435.
Originalarbeiten (Zeitschrift)
Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application.
Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D;
Regen Med. 2007; 2(4):371-382
Originalarbeiten (Zeitschrift)
Immune cells mimic the morphology of endothelial progenitor colonies in vitro.
Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D;
Stem Cells. 2007; 25(7):1746-1752
Originalarbeiten (Zeitschrift)
Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.
Schallmoser, K; Bartmann, C; Rohde, E; Reinisch, A; Kashofer, K; Stadelmeyer, E; Drexler, C; Lanzer, G; Linkesch, W; Strunk, D;
Transfusion. 2007; 47(8):143-146
Originalarbeiten (Zeitschrift)
Association of circulating endothelial progenitor cell growth in patients with Type 2 diabetes with type of glucose-lowering treatment.
Sourij, H; Strunk, D; Rohde, E; Wascher, TC
Diabet Med. 2007; 24(8):926-927
Letter
Roscovitine in B-chronic lymphocytic leukemia cells: high apoptosis-inducing efficacy and synergism with alemtuzumab independent of the patients" pretreatment status.
Weingrill, E; Wolfler, A; Strunk, D; Linkesch, W; Sill, H; Liebmann, PM
HAEMATOL-HEMATOL J. 2007; 92(9): 1286-1288.
Letter
Diagnostic value of Vbeta2-positive T-cell expansion in toxic shock syndrome.
Wenisch, C; Strunk, D; Krause, R; Smolle, KH
INT J DERMATOL. 2007; 46(6): 57-82.
Fallberichte

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Human platelet-derived factors induce differential gene expression in bone marrow mesenchymal stem cells
Bartmann, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
HAEMATOL-HEMATOL J. 2007; 92: 318-318.
Abstracts (Zeitschrift)
Decreased chronic GVHD rate after reduced intensity conditioning with low dose ATG in allogeneic hematopoietic SCT
Langner, S; Staber, P; Strunk, D; Linkesch, W
HAEMATOL-HEMATOL J. 2007; 92: 220-220.
Abstracts (Zeitschrift)
Gene expression profiling of human multipotent mesenchymal stromal cells
Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2007; 39: S51-S51.
Abstracts (Zeitschrift)
Clinical scale propagation of functional cord blood stem cells in a humanized system
Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bielic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D
HAEMATOL-HEMATOL J. 2007; 92: 318-318.
Abstracts (Zeitschrift)
Clinical scale expansion of human cord blood-derived multipotent stem cells in a new FBS-free system
Reinisch, A; Malischnik, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2007; 39: S132-S133.
Abstracts (Zeitschrift)
Immune cells mimic the morphology of endothelial progenitor colonies in vitro
Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
HAEMATOL-HEMATOL J. 2007; 92: 315-315.
Abstracts (Zeitschrift)
Immune cells mimic endothelial progenitor colonies
Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
TRANSFUSION. 2007; 47(3): 69A-69A.
Abstracts (Zeitschrift)
Immune cells mimic endothelial progenitor colonies
Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
BONE MARROW TRANSPL. 2007; 39: S123-S123.
Abstracts (Zeitschrift)
Radioimmunotherapy as a promising therapeutic option in patients with relapsed or refractory CD20(+) non-Hodgkins lymphoma
Rohn, A; Leitner, C; Brezinschek, RI; Sormann, S; Linkesch, W; Strunk, D
HAEMATOL-HEMATOL J. 2007; 92: 278-278.
Abstracts (Zeitschrift)
A novel system for highly efficient clinical scale propagation of human mesenchymal stem cells with human platelet lysate
Schallmoser, K; Bartmarm, C; Rohde, E; Reinisch, A; Kashofer, K; Emberger, W; Lanzer, G; Linkesch, W; Strunk, D
HAEMATOL-HEMATOL J. 2007; 92: 317-318.
Abstracts (Zeitschrift)
Two steps to clinical multipotent mesenchymal stromal cells with human platelet lysate
Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Kashofer, K; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2007; 39: S110-S110.
Abstracts (Zeitschrift)
Animal serum-free clinical scale propagation of human MSC
Schallmoser, K; Reinisch, A; Bartmann, C; Rohde, E; Kashofer, K; Emberger, W; Lanzer, G; Linkesch, W; Strunk, D
TRANSFUSION. 2007; 47(3): 28A-28A.
Abstracts (Zeitschrift)

2006

Beiträge in Fachzeitschriften

CD45-positive cells of haematopoietic origin enhance chondrogenic marker gene expression in rat marrow stromal cells.
Ahmed, N; Vogel, B; Rohde, E; Strunk, D; Grifka, J; Schulz, MB; Grassel, S
Int J Mol Med. 2006; 18(2):233-240
Originalarbeiten (Zeitschrift)
Blood monocytes mimic endothelial progenitor cells.
Rohde, E; Malischnik, C; Thaler, D; Maierhofer, T; Linkesch, W; Lanzer, G; Guelly, C; Strunk, D
Stem Cells. 2006; 24(2):357-367
Originalarbeiten (Zeitschrift)
Stem cell therapy for ischemic heart disease: beginning or end of the road?
Stamm, C; Liebold, A; Steinhoff, G; Strunk, D
CELL TRANSPLANT. 2006; 15 Suppl 1: S47-S56.
Übersichtsarbeiten

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Preclinical protocol: two steps to propagate human MSC for therapeutic application
Malischnik, C; Rohde, E; Thaler, D; Linkesch, W; Lanzer, G; Strunk, D
BONE MARROW TRANSPL. 2006; 37: S152-S152.
Abstracts (Zeitschrift)
Human platelet-derived factors regulate mesenchymal stem cell gene expression.
Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
BLOOD. 2006; 108(11): 142B-142B.
Abstracts (Zeitschrift)
Immune cells mimic endothelial progenitor colonies.
Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D
BLOOD. 2006; 108(11): 513A-513A.
Abstracts (Zeitschrift)
Molecular mimicry: monocytes display endothelial cell related marker molecules
Rohde, E; Malischnik, C; Thaler, D; Maierhofer, T; Linkesch, W; Lanzer, G; Guelly, C; Strunk, D
BONE MARROW TRANSPL. 2006; 37: S24-S24.
Abstracts (Zeitschrift)
Human mesenchymal stem cell therapy: Platelet lysate supports efficient preclinical expansion.
Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D
BLOOD. 2006; 108(11): 1042A-1042A.
Abstracts (Zeitschrift)

2005

Beiträge in Fachzeitschriften

Phenotypic characterization and preclinical production of human lineage-negative cells for regenerative stem cell therapy.
Strunk, D; Rohde, E; Lanzer, G; Linkesch, W
Transfusion. 2005; 45(3):315-326
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Low plating density boosts mesenchymal stem cell proliferation
Malischnika, C; Rohde, E; Thaler, D; Vogel, B; Linkesch, W; Lanzer, G; Schaider, H; Strunk, D
BONE MARROW TRANSPL. 2005; 35: S139-S140.
Abstracts (Zeitschrift)
Human lineage-negative cells for regenerative stem cell therapy
Rohde, E; Brulport, M; Malischnik, C; Thaler, D; Lanzer, G; Linkesch, W; Hengstler, J; Strunk, D
BONE MARROW TRANSPL. 2005; 35: S99-S100.
Abstracts (Zeitschrift)
How to define endothelial progenitor cells in human blood?
Rohde, E; Malischnik, C; Linkesch, W; Lanzer, G; Strunk, D
BONE MARROW TRANSPL. 2005; 35: S78-S78.
Abstracts (Zeitschrift)
Environmental conditioning of CFU-EC by primed blood monocytes
Thaler, D; Rohde, E; Malischnik, C; Linkesch, W; Lanzer, G; Strunk, D
BONE MARROW TRANSPL. 2005; 35: S115-S115.
Abstracts (Zeitschrift)

2004

Beiträge in Fachzeitschriften

Sunburn cell formation, dendritic cell migration, and immunomodulatory factor production after solar-simulated irradiation of sunscreen-treated human skin explants in vitro.
Hofmann-Wellenhof, R; Smolle, J; Roschger, A; Strunk, D; Hubmer, M; Hoffmann, C; Quehenberger, F; Horn, M; Kerl, H; Wolf, P
J INVEST DERMATOL. 2004; 123(4): 781-787.
Originalarbeiten (Zeitschrift)
Neutrophilic leukemoid reaction as the presenting feature of de novo and therapy-related acute leukemias.
Olipitz, W; Strunk, D; Beham-Schmid, C; Sill, H
ACTA HAEMATOL-BASEL. 2004; 111(4): 233-234.
Fallberichte
RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications.
Schmidt, HH; Strehl, S; Thaler, D; Strunk, D; Sill, H; Linkesch, W; Jager, U; Sperr, W; Greinix, HT; Konig, M; Emberger, W; Haas, O
LEUKEMIA. 2004; 18(6): 1115-1121.
Originalarbeiten (Zeitschrift)
Dendritic cell deficiency in early B cell chronic lymphocytic leukemia.
Strunk, D; Grube, R; Stodelmeyer, E; Linkesch, W
HAEMATOLOGICA. 2004; 89(1): 111-112.
Letter

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Human lineage-negative cells for regenerative stem cell therapy
Rohde, E; Thaler, D; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2004; 33: S171-S172.
Abstracts (Zeitschrift)

2003

Beiträge in Fachzeitschriften

inv(3)(q21q26) in AML/MDS: Monitoring of the malignant clone with interphase FISH.
Schmidt, HH; Pirc-Danoewinata, H; Linkesch, W; Strunk, D; Wieser, R;
Haematologica. 2003; 88(12): ECR38
Fallberichte

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Characterization of human lineage-negative cells for regenerative stem cell therapy
Rohde, E; Lanzer, G; Linkesch, W; Strunk, D
BONE MARROW TRANSPL. 2003; 31: S203-S203.
Abstracts (Zeitschrift)
Prevalence of CD7(+) cells in CD34(-)/Lin(-) human hematopoietic stem cell fractions
Rohde, E; Lanzer, G; Linkesch, W; Strunk, D
TRANSFUSION. 2003; 43(9): 52A-53A.
Abstracts (Zeitschrift)
Immunophenotypic analysis and preclinical GMP-grade production of human lineage-negative cells for regenerative stem cell therapy.
Rohde, E; Lanzer, G; Linkesch, W; Strunk, D
BLOOD. 2003; 102(11): 463A-463A.
Abstracts (Zeitschrift)

2002

Beiträge in Fachzeitschriften

Restoration of erythropoiesis by rituximab in an adult patient with primary acquired pure red cell aplasia refractory to conventional treatment.
Auner, HW; Wolfler, A; Beham-Schmid, C; Strunk, D; Linkesch, W; Sill, H
BRIT J HAEMATOL. 2002; 116(3): 727-728.
Fallberichte
Impaired dendritic cell function in B-CLL
Strunk, D; Grube, R; Stadelmeyer, E; Chraust, S; Linkesch, W
. 2002; 205-209.
Originalarbeiten (Zeitschrift)

2001

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

UV-induced TNF alpha production is influenced by the application of sunscreens
Hofmann-Wellenhof, R; Smolle, J; Roschger, A; Strunk, D; Hubmer, M; Hoffmann, C; Horn, M; Kerl, H; Wolf, P
J INVEST DERMATOL. 2001; 117(3): 814-814.
Abstracts (Zeitschrift)
Alteration of dendritic cell function in B-CLL.
Stadelmeyer, E; Grube, R; Chraust, S; Linkesch, W; Strunk, D
BLOOD. 2001; 98(11): 287B-287B.
Abstracts (Zeitschrift)

2000

Beiträge in Fachzeitschriften

Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin"s lymphoma.
Neumeister, P; Strunk, D; Apfelbeck, U; Sill, H; Linkesch, W
LANCET. 2000; 355(9212): 1334-1335.
Letter

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

UV-irradiation of human skin explants reduced migration of dendritic cells
Hofmann-Wellenhof, R; Strunk, D; Wolf, P; Hubmer, M; Legat, F; Smolle, J; Kerl, H
J INVEST DERMATOL. 2000; 114(1): 227-227.
Abstracts (Zeitschrift)

1999

Beiträge in Fachzeitschriften

Separation of sperm and vaginal cells based on ploidy, MHC class I-, CD45-, and cytokeratin expression for enhancement of DNA typing after sexual assault.
Schoell, WMJ; Klintschar, M; Mirhashemi, R; Strunk, D; Giuliani, A; Bogensberger, G; Pertl, B
Cytometry. 1999; 36(4):319-323
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Peripheral blood dendritic cell deficiency in chronic lymphocytic leukemia (CLL) patients.
Grube, R; Chraust, S; Linkesch, W; Strunk, D
BLOOD. 1999; 94(10): 121A-121A.
Abstracts (Zeitschrift)
Human monocytes do not differentiate into Langerhans cells.
Schloegl, D; Chraust, S; Linkesch, W; Strunk, D
BLOOD. 1999; 94(10): 267B-267B.
Abstracts (Zeitschrift)

1998

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Capillary leak syndrome with late onset after autografting for multiple myeloma.
Schmidt, HH; Sill, H; Jager, G; Neumeister, P; Strunk, D; Linkesch, W
BONE MARROW TRANSPL. 1998; 21: S91-S91.
Abstracts (Zeitschrift)

1997

Beiträge in Fachzeitschriften

A skin homing molecule defines the langerhans cell progenitor in human peripheral blood.
Strunk, D; Egger, C; Leitner, G; Hanau, D; Stingl, G
J Exp Med. 1997; 185(6):1131-1136
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Acute myelogenous leukemia cells can be differentiated into dendritic cells in vitro.
Strunk, D; Linkesch, W
BLOOD. 1997; 90(10): 829-829.
Abstracts (Zeitschrift)

1996

Beiträge in Fachzeitschriften

Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells.
Strunk, D; Rappersberger, K; Egger, C; Strobl, H; Kromer, E; Elbe, A; Maurer, D; Stingl, G
Blood. 1996; 87(4):1292-1302
Originalarbeiten (Zeitschrift)
Single human T cells stimulated in the absence of feeder cells transcribe interleukin-2 and undergo long-term clonal growth in response to defined monoclonal antibodies and cytokine stimulation.
SunderPlassmann, R; Breiteneder, H; Zimmermann, K; Strunk, D; Majdic, O; Knapp, W; Holter, W
Blood. 1996; 87(12):5179-5184
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

IL-4 enhances the yield and the immunostimulatory potency of murine bone marrow-derived dendritic cells.
Schneeberger, A; Koszik, F; Lenz, P; Kolesaric, A; Scheinecker, C; Strunk, D; Grauer, O; Kampgen, E; Elbe, A; Stingl, G
J INVEST DERMATOL. 1996; 107(3): 232-232.
Abstracts (Zeitschrift)
A skin homing receptor defines the progenitor of skin Langerhans cells in peripheral blood.
Strunk, D; Egger, C; Stingl, G
BLOOD. 1996; 88(10): 746-746.
Abstracts (Zeitschrift)

1995

Beiträge in Fachzeitschriften

Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture.
PLETTENBERG, A; BALLAUN, C; PAMMER, J; MILDNER, M; STRUNK, D; WENINGER, W; TSCHACHLER, E
Am J Pathol. 1995; 146(3):651-659
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

A SKIN HOMING MOLECULE DEFINES THE PROGENITOR OF DENDRITIC LANGERHANS CELLS
STRUNK, D; EGGER, C; STINGL, G
J INVEST DERMATOL. 1995; 105(3): 461-461.
Abstracts (Zeitschrift)

1994

Beiträge in Fachzeitschriften

Fetal skin-derived MHC class I+, MHC class II- dendritic cells stimulate MHC class I-restricted responses of unprimed CD8+ T cells.
ELBE, A; SCHLEISCHITZ, S; STRUNK, D; STINGL, G
J Immunol. 1994; 153(7):2878-2889
Originalarbeiten (Zeitschrift)
Expression of monoclonal antibody HECA-452-defined E-selectin ligands on Langerhans cells in normal and diseased skin.
KOSZIK, F; STRUNK, D; SIMONITSCH, I; PICKER, LJ; STINGL, G; PAYER, E
J Invest Dermatol. 1994; 102(5):773-780
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

FUNCTIONAL EXPRESSION OF THE COSTIMULATORY MOLECULE-B7 ON ACCESSORY CELLS FOR MHC CLASS I-RESTRICTED IMMUNE-RESPONSES
ELBE, A; REISER, H; STRUNK, D; STINGL, G
J CELL BIOCHEM. 1994; 308-308.
Abstracts (Zeitschrift)
HUMAN MELANOCYTES AND MELANOMA-CELLS EXPRESS THE BCL-2 PROTOONCOGENE IN-SITU AND IN CELL-CULTURE
PLETTENBERG, A; BALLAUN, C; PAMMER, J; MILDNER, M; STRUNK, D; WENINGER, W; TSCHACHLER, E
J INVEST DERMATOL. 1994; 103(3): 436-436.
Abstracts (Zeitschrift)
EXPRESSION OF THE BCL-2 PROTOONCOGENE IN NORMAL HUMAN EPIDERMIS
PLETTENBERG, A; BALLAUN, C; STRUNK, D; WENINGER, W; TSCHACHLER, E
J INVEST DERMATOL. 1994; 102(4): 645-645.
Abstracts (Zeitschrift)
LANGERHANS CELLS CAN BE GENERATED FROM CIRCULATING CD34+ PROGENITORS
STRUNK, D; ELBE, A; RAPPERSBERGER, K; STINGL, G
J INVEST DERMATOL. 1994; 103(3): 408-408.
Abstracts (Zeitschrift)
GENERATION OF LANGERHANS CELLS FROM PERIPHERAL-BLOOD STEM-CELLS
STRUNK, D; NEMETH, P; ELBE, A; RAPPERSBERGER, K; STINGL, G
FASEB J. 1994; 8(5): A989-A989.
Abstracts (Zeitschrift)
GENERATION OF LANGERHANS CELLS FROM CD34+ PERIPHERAL-BLOOD STEM-CELLS
STRUNK, D; NEMETH, P; ELBE, A; RAPPERSBERGER, K; STINGL, G
J INVEST DERMATOL. 1994; 102(4): 525-525.
Abstracts (Zeitschrift)

1993

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

THE CUTANEOUS LYMPHOCYTE-ASSOCIATED ANTIGEN IS EXPRESSED ON LANGERHANS CELLS IN NORMAL AND DISEASED SKIN
KOSZIK, F; STRUNK, D; STINGL, G; PAYER, E
J INVEST DERMATOL. 1993; 100(4): 442-442.
Abstracts (Zeitschrift)
A SUBPOPULATION OF LANGERHANS CELLS IN NORMAL AND DISEASED SKIN EXPRESS CUTANEOUS LYMPHOCYTE-ASSOCIATED ANTIGEN
PAYER, E; KOSZIK, F; STRUNK, D; STINGL, G
J INVEST DERMATOL. 1993; 100(4): 572-572.
Abstracts (Zeitschrift)
A SUBPOPULATION OF LANGERHANS CELLS IN NORMAL AND DISEASED SKIN EXPRESS CUTANEOUS LYMPHOCYTE-ASSOCIATED ANTIGEN
PAYER, E; KOSZIK, F; STRUNK, D; STINGL, G
CLIN RES. 1993; 41(2): A471-A471.
Abstracts (Zeitschrift)
MIGRATION KINETICS OF HUMAN EPIDERMAL LANGERHANS CELLS
STRUNK, D; ELBE, A; STINGL, G
J INVEST DERMATOL. 1993; 100(4): 574-574.
Abstracts (Zeitschrift)
MIGRATION KINETICS OF HUMAN EPIDERMAL LANGERHANS CELLS
STRUNK, D; ELBE, A; STINGL, G
CLIN RES. 1993; 41(2): A473-A473.
Abstracts (Zeitschrift)

1992

Beiträge in Fachzeitschriften

Inhibition of histamine release from human granulocytes by ions of the rare earth elements lanthanum and cerium.
GRUNER, S; SEHRT, I; MULLER, GM; ZWIRNER, A; STRUNK, D; SONNICHSEN, N
Agents Actions. 1992; 36(3-4):207-211
Originalarbeiten (Zeitschrift)
The influence of topical dermatological treatment modalities on epidermal Langerhans cells and contact sensitization in mice.
GRUNER, S; ZWIRNER, A; STRUNK, D; SONNICHSEN, N
Contact Dermatitis. 1992; 26(4):241-247
Originalarbeiten (Zeitschrift)

1991

Beiträge in Fachzeitschriften

Inhibition of Langerhans cell ATPase and contact sensitization by lanthanides--role of T-suppressor cells.
GRUNER, S; DIEZEL, W; STRUNK, D; ECKERT, R; SIEMS, W; ANHALT, GJ
J Invest Dermatol. 1991; 97(3):478-482
Originalarbeiten (Zeitschrift)

1990

Beiträge in Fachzeitschriften

Stimulation of the recruitment of epidermal Langerhans cells by splenopentin.
GRUNER, S; DIEZEL, W; STRUNK, D; ZWIRNER, A; SONNICHSEN, N; ANHALT, GJ
Arch Dermatol Res. 1990; 281(8):526-529
Originalarbeiten (Zeitschrift)

1989

Beiträge in Fachzeitschriften

[Contact hypersensitivity (DNCB test) and inhibition by the calcium channel blocker diltiazem].
Diezel, W; Gruner, S; Anhalt, GJ; Strunk, D; Shanks, M; Sönnichsen, N;
Dermatol Monatsschr. 1989; 175(3): 170-174.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

SUPPRESSION OF CUTANEOUS CONTACT HYPERSENSITIVITY BY LANTHANUM
DIEZEL, W; GRUNER, S; STRUNK, D; ECKERT, R; SIEMS, W; DIAZ, LA; ANHALT, GJ
CLIN RES. 1989; 37(2): A349-A349.
Abstracts (Zeitschrift)

1987

Beiträge in Fachzeitschriften

[Effect of topical antipsoriatic agents on ATPase-positive epidermal Langerhans cells. Animal experiment studies].
Gruner, S; Strunk, D; Diezel, W;
Dermatol Monatsschr. 1987; 173(8):436-440
Originalarbeiten (Zeitschrift)